Immatics N.V. Warrants

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch IMTXW and buy or sell other stocks, ETFs, and their options commission-free!

About IMTXW

Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. Its pipeline includes adoptive cell therapy and TCR Bispecifics. 

CEO
Harpreet Singh-Jasuja, PhD
CEOHarpreet Singh-Jasuja, PhD
Employees
—
Employees—
Headquarters
Tuebingen, Baden Wuerttemberg
HeadquartersTuebingen, Baden Wuerttemberg
Founded
2020
Founded2020
Employees
—
Employees—

IMTXW Key Statistics

Market cap
—
Market cap—
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
12.45K
Average volume12.45K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$3.45
52 Week high$3.45
52 Week low
$0.0006
52 Week low$0.0006

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.